Nyxoah SA ROA 2021-2024 | NYXH
Nyxoah SA ROA - Return on Assets Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Total Assets | Return on Assets |
2024-09-30 | $-0.06B | $0.16B | -40.42% |
2024-06-30 | $-0.05B | $0.16B | -33.39% |
2024-03-31 | $-0.05B | $0.12B | -33.69% |
2023-12-31 | $-0.05B | $0.13B | -31.49% |
2023-09-30 | $-0.05B | $0.15B | -31.77% |
2023-06-30 | $-0.05B | $0.16B | -29.56% |
2023-03-31 | $-0.04B | $0.16B | -23.07% |
2022-12-31 | $-0.03B | $0.15B | -19.33% |
2022-03-31 | $-0.02B | $0.19B | -13.33% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MEDICAL INFO SYS | $0.352B | $0.005B |
Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. |